Literature DB >> 3029191

Kaposi's sarcoma and acquired immunodeficiency syndrome. Postmortem findings in twenty-four cases.

G Lemlich, L Schwam, M Lebwohl.   

Abstract

Autopsy results on twenty-four patients with acquired immunodeficiency syndrome (AIDS) and Kaposi's sarcoma were reviewed. At postmortem, 29% of patients had evidence of visceral Kaposi's sarcoma without skin lesions. The most common sites for visceral involvement with Kaposi's sarcoma were as follows: lung (37%), gastrointestinal tract (50%), and lymph nodes (50%). At the time of death, only 25% of patients had evidence of cutaneous disease alone. The patients survived up to 36 months after the diagnosis of AIDS was made according to the specific diagnostic criteria established by the Centers for Disease Control. Many of the patients had severe, disseminated infections during the course of their AIDS illness. The most common infections diagnosed during the patients' clinical courses and/or at autopsy were cytomegalovirus (75%), candidiasis (50%), Mycobacterium avium intracellulare (50%), Pneumocystis carinii pneumonia (50%), bacterial pneumonia (33%), and herpes simplex virus (29%). Nearly 80% of the deaths were attributed to infection. In only one case was overwhelming Kaposi's sarcoma determined to be the cause of death.

Entities:  

Mesh:

Year:  1987        PMID: 3029191     DOI: 10.1016/s0190-9622(87)70043-7

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


  6 in total

1.  Kaposi's sarcoma in dog with acquired immunodeficiency after phosphate poisoning.

Authors:  B Sýkora; A Tomsíková
Journal:  Folia Microbiol (Praha)       Date:  1998       Impact factor: 2.099

2.  Sézary syndrome, Kaposi sarcoma and generalized dermatophytosis 15 years after sulfur mustard gas exposure.

Authors:  Seyed Naser Emadi; Farhang Babamahmoodi; Zohreh Poursaleh; Seyede Somaye Sayad-Noori; Mohammad Reza Soroush; Ali Reza Maleki; Morteza Izadi; Mohammad Reza Khodaei-Ardakan; Seyed Emad Emadi
Journal:  J Dermatol Case Rep       Date:  2012-09-28

3.  Potent antiviral activity of north-methanocarbathymidine against Kaposi's sarcoma-associated herpesvirus.

Authors:  Weimin Zhu; Angela Burnette; Dorjbal Dorjsuren; Paula E Roberts; Mahmoud Huleihel; Robert H Shoemaker; Victor E Marquez; Riad Agbaria; Shizuko Sei
Journal:  Antimicrob Agents Chemother       Date:  2005-12       Impact factor: 5.938

Review 4.  Hepatic Kaposi sarcoma: A case report and review of the literature.

Authors:  Brett Van Leer-Greenberg; Abhisake Kole; Saurabh Chawla
Journal:  World J Hepatol       Date:  2017-02-08

5.  Primary pulmonary Kaposi Sarcoma in a newly diagnosed cisgender heterosexual HIV positive patient presenting before cutaneous manifestations.

Authors:  Sarah Khan; Jolie Guevara; Ana Barbosa; Awista Ayuby; Fred Bien-Aime; Larissa Verda; Nancy Glick; Vikas Mehta
Journal:  IDCases       Date:  2018-07-03

6.  Human Immunodeficiency Virus-Associated Gastrointestinal Kaposi's Sarcoma: A Case Report.

Authors:  Hee Joong Lim; So Hyun Park; Seung Joon Choi; Suyoung Park; Hee Young Lee; Jun Won Chung; Dong Hae Chung
Journal:  Taehan Yongsang Uihakhoe Chi       Date:  2020-08-13
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.